List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #881 to #930.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. APAlkaline phosphatase
  2. AP-1 siteAP-1 Binding Site
  3. APAFAblation For Paroxysmal Atrial Fibrillation (Apaf) Trial
  4. APAPParacetamol detailed information
  5. APASSAntiphospholipid Antibody Stroke Study
  6. APBPremature atrial contraction
  7. APCEDSAutoimmune polyendocrine syndrome
  8. APC Resistance, Leiden TypeFactor V Leiden
  9. APC geneAPC (gene)
  10. APC resistanceActivated protein C resistance
  11. APC resistance, Leiden typeFactor V Leiden
  12. APDAvoidant personality disorder
  13. APECEDAutoimmune polyendocrine syndrome
  14. APECED syndromeAutoimmune polyendocrine syndrome
  15. APEX AMIAssessment Of Pexelizumab In Acute Myocardial Infarction
  16. APHAntepartum haemorrhage
  17. API Healthcare Coloufree Childrens ParacetamolParacetamol detailed information
  18. API Healthcare Colourfree Childrens Paracetamol Double StrengthParacetamol detailed information
  19. API Healthcare ParacetamolParacetamol detailed information
  20. APLAcute promyelocytic leukemia
  21. APLAUSEAnti-Platelet Treatment After Intravascular Ultrasound Guided Optimal Stent Expansion
  22. APL differentiation syndromeRetinoic acid syndrome
  23. APMLAcute promyelocytic leukemia
  24. APML differentiation syndromeRetinoic acid syndrome
  25. APO-AtenolAtenolol
  26. APO-GoApomorphine
  27. APO-Go PenApomorphine
  28. APOCARDImaging In Cardiac Transplant Patients
  29. APPIAmyloid precursor protein
  30. APPRAISE-1Safety Of The Factor Xa Inhibitor, Apixaban, In Combination With Antiplatelet Therapy After Acute Coronary Syndromes: A Dose-Guiding Trial
  31. APPROACHAssessment On The Prevention Of Progression By Rosiglitazone On Atherosclerosis In Diabetes Patients With Cardiovascular History
  32. APRESAngiotensin-Converting Enzyme Inhibition Post Revascularization Study
  33. APRICOTAntithrombotics In The Prevention Of Reocclusion In Coronary Thrombolysis
  34. APRICOT-2Antithrombotics In The Prevention Of Reocclusion In Coronary Thrombolysis-2
  35. APS1Autoimmune polyendocrine syndrome
  36. APS 1Autoimmune polyendocrine syndrome
  37. APS type 1Autoimmune polyendocrine syndrome
  38. APS type 2Autoimmune polyendocrine syndrome
  39. APS type 3Autoimmune polyendocrine syndrome
  40. APTAmiodarone pulmonary toxicity
  41. APTTPartial thromboplastin time
  42. APTXAprataxin
  43. APUDoma of skinMerkel cell cancer
  44. APUDoma of the skinMerkel cell cancer
  45. AP endonucleasesAP endonuclease
  46. AQP1Aquaporin 1
  47. ARAortic regurgitation
  48. AR-CMT2Charcot-Marie-Tooth Syndrome
  49. ARBAngiotensin II receptor antagonist
  50. ARBITER 2Arterial Biology For The Investigation Of The Treatment Effects Of Reducing Cholesterol 2

View ( | ) (20 | 50 | 100 | 250 | 500)